Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“Antibody-drug conjugates are poised to reshape standards of care across several diseases.
At ASCO 2025, we’ll see results from highly awaited trials in breast, gastric, lung, GU oncology and beyond.
Here’s a list of 10 ADC presentations not to miss at the conference, curated by Raffaele Colombo and myself.”
More posts featuring ASCO 2025.